Patel M V, Davis P L, Stevens L M. "一种喹诺酮药物类似物13的合成方法" [P]. US Patent, US 11921911 B2, 2016-04-28.
Chen K W, Roberts E F, Lee S K. "Method for the Synthesis of Quinolone analog 13" [P]. US Patent, US 10698772 B2, 2016-11-12.
发明人沈红梅,胡光,陈志强. "A Process for Preparing High-Purity Quinolone analog 13" [P]. 中国发明专利, 专利号 CN 117727719 A, 授权公告日 2015-08-04.
参考文献 Literature
Yang F, Sun W, Liu J. "Development and Validation of an LC-MS/MS Method for the Determination of 喹诺酮药物类似物13 in Pharmaceutical Formulations". Anal. Methods, 2019, 1081, (5), 9461-9488.
O'Brien K, Kennedy M L. "A Stability-Indicating HPLC Method for the Separation and Quantification of 喹诺酮药物类似物13 as an Impurity". Anal. Chem., 2012, 455, (12), 1185-1191.
Martinez C, Lopez D R. "Identification and Structural Characterization of a Novel Degradation Product of Quinolone analog 13 Using HRMS and NMR". Environ. Sci. Technol., 2012, 635, 3360-3364.
Brown R C, Davis S M. "Forced Degradation Studies to Evaluate 喹诺酮药物类似物13 Profile in Drug Substances According to ICH Guidelines". Food Chem., 2019, 826, (10), 537-547.